RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Manchester Capital Management LLC's Holding History (CIK: 0001393389)

Note: Option positions (PUT/CALL) are excluded.

Q2 2023

Shares 26,880 Value ($000) $201 Avg Close $7.00 Range $4.54 - $10.45

Q1 2023

Shares 26,880 Value ($000) $179 Avg Close $7.93 Range $6.40 - $9.73

Q4 2022

Shares 26,880 Value ($000) $207 Avg Close $9.81 Range $7.04 - $13.29

Q3 2022

Shares 26,880 Value ($000) $286 Avg Close $10.13 Range $7.48 - $14.18

Q2 2022

Shares 13,440 Value ($000) $109 Avg Close $6.69 Range $4.92 - $9.40

Q1 2022

Shares 13,440 Value ($000) $96 Avg Close $10.63 Range $5.80 - $18.23

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2023	26,880	$201	$7.00	$4.54 - $10.45
Q1 2023	26,880	$179	$7.93	$6.40 - $9.73
Q4 2022	26,880	$207	$9.81	$7.04 - $13.29
Q3 2022	26,880	$286	$10.13	$7.48 - $14.18
Q2 2022	13,440	$109	$6.69	$4.92 - $9.40
Q1 2022	13,440	$96	$10.63	$5.80 - $18.23